LAX.SH
INDRAPRASTHA MEDICAL CORP·HOSPITALS 65.95·Healthcare Services Companies
Price
369.7
-1.89%52W Range
Market Cap
₹3,389.15 Cr
Traded: ₹5.35 Cr (0.16%) 0.0x
Free Float: ₹1,343.46 Cr (0.40% of FF traded)
Volume · 60D trend
1.43 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +7.0% | +19.0% | +11.0% | -- | +9.0% | Decelerating |
| ROE | +21.0% | +27.0% | +29.0% | -- | -- | Accelerating |
| Return | +22.0% | +33.0% | +64.0% | -8.0% | -- | Stable |
| Profit | +22.0% | +132.0% | +28.0% | -- | +14.0% | Decelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 406 | 365 | 372 | 381 | 365 | 334 | 325 | 350 | 348 | 315 | 306 | 317 | 307 | 274 |
| Expenses | 326 | 304 | 310 | 310 | 292 | 272 | 273 | 286 | 281 | 266 | 259 | 267 | 259 | 241 |
| Operating Profit | 80 | 61 | 62 | 71 | 73 | 61 | 52 | 64 | 67 | 48 | 47 | 50 | 47 | 33 |
| OPM % | 20.0% | 17.0% | 17.0% | 19.0% | 20.0% | 18.0% | 16.0% | 18.0% | 19.0% | 15.0% | 15.0% | 16.0% | 15.0% | 12.0% |
| Other Income | 8 | 7 | 7 | 7 | 7 | 6 | 5 | 6 | 5 | 5 | 4 | 4 | 4 | 5 |
| Interest | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 12 | 11 | 11 | 11 | 10 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 10 |
| Profit Before Tax | 75 | 55 | 56 | 66 | 68 | 55 | 45 | 57 | 60 | 42 | 41 | 44 | 40 | 27 |
| Tax % | 25.0% | 24.0% | 27.0% | 25.0% | 25.0% | 26.0% | 26.0% | 26.0% | 25.0% | 25.0% | 28.0% | 25.0% | 24.0% | 27.0% |
| Net Profit | 56 | 42 | 41 | 49 | 51 | 41 | 33 | 42 | 45 | 31 | 29 | 33 | 30 | 20 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 6.1 | 4.5 | 4.5 | 5.4 | 5.6 | 4.5 | 3.6 | 4.6 | 4.9 | 3.4 | 3.2 | 3.6 | 3.3 | 2.2 |
| Sales Growth (YoY) | 11.3% | 9.3% | 14.4% | 8.9% | 4.9% | 6.0% | 6.0% | 10.3% | 13.5% | 14.8% | 10.7% | 11.5% | 16.4% | -- |
| Sales Growth (QoQ) | -- | -1.9% | -2.4% | 4.4% | 9.3% | 2.8% | -7.1% | 0.6% | 10.5% | 2.9% | -3.5% | 3.3% | 12.0% | -- |
| OP Growth (YoY) | 9.6% | 0.0% | 19.2% | 10.9% | 9.0% | 27.1% | 10.6% | 28.0% | 42.6% | 45.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 31.1% | -1.6% | -12.7% | -2.7% | 19.7% | 17.3% | -18.8% | -4.5% | 39.6% | 2.1% | -6.0% | 6.4% | 42.4% | -- |
| Profit Growth (YoY) | -- | 1.7% | 25.0% | 16.6% | 14.9% | 31.6% | 11.4% | 29.1% | 46.8% | 57.1% | 40.9% | 30.7% | 50.4% | 30.5% |
| EPS Growth (YoY) | -- | 1.8% | 24.9% | 16.6% | 15.0% | 31.5% | 11.5% | 29.3% | 46.5% | 57.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 1.8% | -17.2% | -3.7% | 25.5% | 24.9% | -22.7% | -5.1% | 43.5% | 5.9% | -10.3% | 7.5% | 54.2% | -- |
| OP Margin | -- | 16.7% | 16.7% | 18.6% | 20.0% | 18.3% | 16.0% | 18.3% | 19.3% | 15.2% | 15.4% | 15.8% | 15.3% | 12.0% |
| Net Margin | -- | 11.5% | 11.0% | 12.9% | 14.0% | 12.3% | 10.2% | 12.0% | 12.9% | 9.8% | 9.5% | 10.4% | 9.8% | 7.3% |
| Material Cost % | -- | 17.6% | 17.2% | 17.2% | 17.2% | 17.7% | 17.3% | 16.1% | 16.9% | 17.6% | 16.5% | 18.0% | 17.7% | 17.2% |
| Employee Cost % | -- | 20.3% | 20.1% | 19.3% | 17.8% | 20.0% | 22.2% | 20.5% | 19.1% | 20.6% | 21.7% | 21.2% | 20.6% | 23.9% |
| P/S | 2.22 | 2.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 18.03 | 18.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.57 | 4.48 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50we hereby submit copies of the public notice of the Financial results , published on 7th August, 2026, in the "Financial Express", all India Editions, in English Language and in " Jansatta", ....
The board of director of the company as its meeting held on 06-08-2026 considered and approved fixation of record date as Friday 18-09-2026 for the purpose of payment of dividend for the ....
The board of directors of the company has at its meeting held on 6th August, 2026 considered and approved convening the 38th AGM of the company on 24th September, 2026 through Video Conferencing\ ....
This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 6th August, 2026 (i.e. today), inter-alia, considered and approved the following items: ....
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve It is hereby ....
Enclosed please find herewith a certificate dated 6th July,2026 issued M/s MUFG Intime india Private Limited Registrar And Share transfer agent of the company quarter ended 30th June, 2026.
it is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons from Wednesday 1 st July, 2026 till 48 hours after the ....
We wishh to inform you that the management of the company intends to engage in discussions with investors/analyst meet on 4th June, 2026 & 5th June, 2026 at Mumbai. Further, please note ....
we wish to inform you that ICRA Limited has vide its letter dated 26th May, 2026, re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation ....
We hereby submit copies of the public notice of the financial results, published on 13th May, 2026, in the "Financial Express", all India editions, in English Language and in " Jansatta", ....
the board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March, 2026, 2. Reccomended a dividend @ 40% i.e., Rs 4 per ....
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Pursuant to ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
We enclose herewith copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares, published on 7th April, 2026, in the ....
Please find herewith a certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for the quarter ended 31st March, 2026.
We hereby inform you that Mr. Vinayak Chatterjee (DIN: 00008933) has completed his tenure viz. second term of five consecutive years on 31st March, 2026, as Independent Director on the ....
We wish to inform you that financial results for the quarter and year ending on 31st March, 2026, along with other matters for which trading window is required to be closed from Wednesday, ....
We hereby submit, voting results of the Postal Ballot Notice dated 3rd February 2026, along with copy of the Scrutinizer report dated 21st march 2026
We hereby submit copies of the public notice of the postal Ballot published on 20th Februrary 2026 in the Financial Express all India Editions and in Jansatta Delhi edition.
Enclosed please find notice for Postal ballot. Seeking approvals of shareholders for appointment/ reappointment of independent directors as per details given in attached notice of postal ballot.
We hereby submits the copy of public notice of financial results published on 4th February, 2026 in Financial Express all India editions in English language and in Jansatta Delhi edition ....
Pursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board of Directors of the Company at its meeting ....
It is hereby informed the board of directors in its meeting held on 03.02.2026, considered and approved the appionment/ re-appiontment of the following : 1. Mr. Harsh Pati Singhania as ....
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve It is hereby ....
Enclosed please find herewith a certificate dated 9/01/2026 issued by M/s MUFG Intime India Pvt Ltd, registrar and share transfer agent of the company for the quarter ended 31/12/2025.
We wish to inform you that the trading window of the company will remain closed from 1st January, 2026 till 48 hours after announcement / declaration of unaudited financial results for ....
we wish to submit that the management of the company intends to participate in the "annual flagship Conference- Anand Rathi G-200 Submit on 13th November, 2025 at Mumbai.
We hereby submit copies of the public notice of the financial results, published on 3rd November, 2025, in the "Financial Express", all India editions, in English language and in "Jansatta", ....
The Board of Directors of the company has at its meeting held on Saturday 1st November 2025, i.e. today, inter alia, consider and approved the un-audited financial results for the quarter ....
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2025 ,inter alia, to consider and approve the meeting ....
Please find herewith a Certificate dated 3rd October, 2025, issued by M/s. MUFG Intime India Pvt. Ltd., Registrar and Transfer Agent of the Company for the quarter ended 30th September, 2025.
we wish to inform you that there is no information / announcement (including impending announcement) to be made by the company which, in our opinion, may have a bearing on the operation/performance ....
The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on October 08, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.
we wish to inform you that, there is no information/ announcement ( including impending announcement) to be made by the company which may have a bearing on the price / volume/ operation/ ....
The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on October 08, 2025 with reference to significant movement in price, in order to ensure that investors have ....
the 37th AGM of the Company was held on 24th September, 2025, through Video Conferencing. In this regard, please find the following:- 1) Voting Results under Regulation 44 of the Listing ....
It is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons including Promoters, Directors, Key Managerial Personnel, ....
We hereby submit per annexure summary of the proceedings of the 37th Annual general Meting of the Company held on 24th September, 2025, through Video Conferencing and Other Audio-Visual Means.
we hereby submit copies of newspaper advertisement for the opening of special window for re-lodgment of the transfer requests of physical shares.
we hereby submit the copies of the public notice for transfer of shares to IEPF, published on 10th September, 2025, in the financial express, all India editions, in English language and ....
we hereby submit copies of the public notice for completion of dispatch of Notice and Annual Report of the 37th AGM, to be held on 24th Septembers, 2025, Remote e-voting and Record date ....
We hereby submit copies of the public notice of the 37th Annual General Meeting, published in the "Financial Express" , all India editions, in English language and in "Jansatta", Delhi ....
Pursuant to regulation 34(1)(a) of the Listing regulations, the Annual report of the Company for the financial year ended 31st March, 2025, along with Notice of the 37th AGM to be held ....
The Annual Report of the company for the financial year ended 31st March, 2025 is hereby attached.
we hereby submit copies of the public notice of the Financial results, published on 7th august, 2025 In Financial express (all India edition) in English language and Jansatta Delhi edition ....
This is to inform you that the board of directors of the company, at its meeting held on Wednesday, 6th August, 2025 (i.e. today) inter-alia considered and approved convening the 37th AGM ....
The board of directors of the company at its meeting held on Wednesday, 6th august, 2025, has fixed the record date as Thursday, 18th September, 2025 for the purpose of determining the ....
This is to inform you that the Board of directors of the company as its meeting held on Wednesday, 6th August, 2025, (i.e., today) inter-alia, considered and approved the following 1. ....
The board of directors of the company has at its meeting held on Wednesday, 6th August, 2025(i.e., today), inter-alia considered and approved the items as follows: 1. The un-audited financial ....
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve this is to ....
Annual Reports
14Held by ETFs
2 ETFs hold indramedco · sorted by weight
Held by Mutual Funds
2 schemes hold indramedco · sorted by weight